Investors
Presentations & Reports 2018
For investor-related information please contact Gabriella Hold at Automic Group
Ph: +61 411 364 382 E: gabriella.hold@automicgroup.com.au
https://www.youtube.com/watch?v=W4qXsc9jeok
Zelda Therapeutics poised to ‘value add al the way from clinical trails to the market’.
December 2, 2018
https://www.youtube.com/watch?v=W4qXsc9jeok
Zelda Therapeutics poised to ‘value add all the way from clinical trails to the market’
December 2, 2018
https://zeliratx.com/presentations/Investor_Presentation_Nondeal_RoadshowNOV2018.pdf
AGM Presentation – Non-deal Roadshow
November 30, 2018
https://zeliratx.com/presentations/Preso_Nov2018.pdf
AGM Presentation
November 30, 2018
https://www.youtube.com/watch?v=hX59nY0gk6s
Zelda enters rapidly-growing German market with product commercialisation strategy
September 9, 2018
https://www.youtube.com/watch?v=hX59nY0gk6s
Zelda enters rapidly-growing German market with product commercialisation strategy
September 9, 2018
https://zeliratx.com/presentations/Investor_Presentation_Non_deal_RoadshowSEPT2018.pdf
Investor Presentation – Non-deal Roadshow
September 1, 2018
https://www.youtube.com/watch?v=NNfK7kcBZrY
Zelda Therapeutics ready to test ‘entourage effect’ hypothesis in cancer research
June 18, 2018
https://www.youtube.com/watch?v=v1qM63hGRPg
Zelda Therapeutics “ahead of the pack”
Zelda Therapeutics “ahead of the pack” in gaining first-mover advantages
May 4, 2018